Avoro Capital Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-2,275,000
| Closed | -$55.1M | – | 41 |
|
2022
Q1 | $55.1M | Buy |
2,275,000
+75,000
| +3% | +$1.82M | 1.01% | 19 |
|
2021
Q4 | $51.3M | Hold |
2,200,000
| – | – | 0.87% | 19 |
|
2021
Q3 | $36.5M | Sell |
2,200,000
-241,658
| -10% | -$4.01M | 0.57% | 27 |
|
2021
Q2 | $59.6M | Sell |
2,441,658
-58,342
| -2% | -$1.42M | 1.04% | 22 |
|
2021
Q1 | $64.5M | Buy |
2,500,000
+550,000
| +28% | +$14.2M | 1.11% | 20 |
|
2020
Q4 | $104M | Buy |
+1,950,000
| New | +$104M | 1.8% | 16 |
|
2020
Q2 | – | Sell |
-145,000
| Closed | -$6.13M | – | 45 |
|
2020
Q1 | $6.13M | Buy |
+145,000
| New | +$6.13M | 0.21% | 40 |
|
2019
Q4 | – | Sell |
-887,500
| Closed | -$31.9M | – | 30 |
|
2019
Q3 | $31.9M | Sell |
887,500
-437,500
| -33% | -$15.7M | 1.33% | 18 |
|
2019
Q2 | $35.4M | Hold |
1,325,000
| – | – | 1.22% | 19 |
|
2019
Q1 | $35.6M | Buy |
+1,325,000
| New | +$35.6M | 1.54% | 19 |
|
2018
Q4 | – | Sell |
-100,000
| Closed | -$2.08M | – | 34 |
|
2018
Q3 | $2.08M | Buy |
+100,000
| New | +$2.08M | 0.1% | 39 |
|
2018
Q2 | – | Sell |
-317,100
| Closed | -$7.13M | – | 42 |
|
2018
Q1 | $7.13M | Buy |
+317,100
| New | +$7.13M | 0.34% | 36 |
|
2017
Q3 | – | Sell |
-614,200
| Closed | -$17.1M | – | 40 |
|
2017
Q2 | $17.1M | Sell |
614,200
-1,015,800
| -62% | -$28.3M | 2.16% | 14 |
|
2017
Q1 | $56M | Buy |
1,630,000
+143,540
| +10% | +$4.93M | 7.16% | 4 |
|
2016
Q4 | $42.9M | Buy |
1,486,460
+693,961
| +88% | +$20M | 8.66% | 1 |
|
2016
Q3 | $25.2M | Buy |
792,499
+462,999
| +141% | +$14.7M | 4.42% | 8 |
|
2016
Q2 | $10.7M | Buy |
+329,500
| New | +$10.7M | 2.38% | 15 |
|
2015
Q4 | – | Sell |
-581,900
| Closed | -$19.2M | – | 29 |
|
2015
Q3 | $19.2M | Buy |
581,900
+86,900
| +18% | +$2.87M | 5% | 6 |
|
2015
Q2 | $20.7M | Buy |
+495,000
| New | +$20.7M | 5.71% | 6 |
|